Cabot (NYSE:CBT – Get Free Report) was upgraded by research analysts at UBS Group from a “hold” rating to a “strong-buy” rating in a note issued to investors on Thursday, Marketbeat reports.
A number of other research firms have also recently issued reports on CBT. Mizuho lifted their target price on shares of Cabot from $72.00 to $80.00 and gave the stock an “outperform” rating in a report on Thursday, December 18th. JPMorgan Chase & Co. cut their price objective on shares of Cabot from $75.00 to $54.00 and set an “underweight” rating for the company in a research report on Friday, November 28th. Zacks Research downgraded Cabot from a “hold” rating to a “strong sell” rating in a research report on Friday, November 7th. Jefferies Financial Group reissued a “buy” rating and set a $81.00 price target on shares of Cabot in a report on Thursday. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Cabot in a research note on Monday, December 29th. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $74.00.
Get Our Latest Stock Analysis on CBT
Cabot Trading Up 1.4%
Cabot (NYSE:CBT – Get Free Report) last released its quarterly earnings data on Monday, November 3rd. The specialty chemicals company reported $1.70 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.72 by ($0.02). Cabot had a net margin of 8.91% and a return on equity of 24.55%. The business had revenue of $899.00 million during the quarter, compared to analyst estimates of $967.02 million. During the same period in the previous year, the business earned $1.80 earnings per share. The business’s quarterly revenue was down 10.2% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. Analysts expect that Cabot will post 7.57 earnings per share for the current year.
Hedge Funds Weigh In On Cabot
Several hedge funds and other institutional investors have recently added to or reduced their stakes in CBT. Norges Bank acquired a new stake in shares of Cabot during the 2nd quarter worth $51,710,000. AQR Capital Management LLC grew its stake in Cabot by 123.0% during the second quarter. AQR Capital Management LLC now owns 867,946 shares of the specialty chemicals company’s stock worth $65,096,000 after buying an additional 478,702 shares in the last quarter. UBS Group AG grew its stake in Cabot by 186.7% during the third quarter. UBS Group AG now owns 593,510 shares of the specialty chemicals company’s stock worth $45,136,000 after buying an additional 386,514 shares in the last quarter. American Century Companies Inc. increased its holdings in Cabot by 11.1% in the 2nd quarter. American Century Companies Inc. now owns 1,664,728 shares of the specialty chemicals company’s stock valued at $124,855,000 after buying an additional 166,460 shares during the period. Finally, Goldman Sachs Group Inc. raised its position in shares of Cabot by 32.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company’s stock valued at $36,802,000 after buying an additional 108,645 shares in the last quarter. 93.18% of the stock is owned by institutional investors and hedge funds.
About Cabot
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.
The company operates two primary segments: Reinforcement Materials and Performance Materials.
See Also
- Five stocks we like better than Cabot
- Why Trump and Musk suddenly care about Fort Knox
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- A Message From An Ex-CIA Officer About Trump
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.
